We have previously reported that during atherosclerotic cardiovascular disease (ASCVD), ADAR1-mediated RNA editing is required for the expression of cathepsin S (CTSS), a matrix degradation enzyme with an important part in the development and progression of ASCVD [14, 42]. The gene discussed is ADAR; the disease is atherosclerosis.